BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35762143)

  • 1. Outcomes of Empirical Treatment With Intravenous Immunoglobulin G Combined With Low-Dose Aspirin in Women With Unexplained Recurrent Pregnancy Loss.
    Kim JH; Kim SH; Yang N; Ko Y; Lee SR; Chae HD
    J Korean Med Sci; 2022 Jun; 37(25):e200. PubMed ID: 35762143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
    Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
    Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High doses of intravenous immunoglobulin stimulate regulatory T cell and suppress natural killer cell in women with recurrent pregnancy loss.
    Yamada H; Deguchi M; Saito S; Takeshita T; Mitsui M; Saito T; Nagamatsu T; Takakuwa K; Nakatsuka M; Yoneda S; Egashira K; Tachibana M; Matsubara K; Honda R; Fukui A; Tanaka K; Sengoku K; Endo T; Yata H
    J Reprod Immunol; 2023 Aug; 158():103977. PubMed ID: 37354783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive outcomes of women with recurrent pregnancy losses and repeated implantation failures are significantly improved with immunomodulatory treatment.
    Sung N; Khan SA; Yiu ME; Jubiz G; Salazar MD; Skariah A; Dambaeva S; Kwak-Kim J
    J Reprod Immunol; 2021 Nov; 148():103369. PubMed ID: 34492567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells.
    Moraru M; Carbone J; Alecsandru D; Castillo-Rama M; García-Segovia A; Gil J; Alonso B; Aguarón A; Ramos-Medina R; Martínez de María J; Oliver-Miñarro D; Rodríguez-Mahou M; Ortega V; Caballero P; Meliá E; Vidal J; Cianchetta-Sivori M; Esteban C; Vargas-Henny L; Dale J; Ortiz-Quintana L; Fernández-Cruz E; Sánchez-Ramón S
    Am J Reprod Immunol; 2012 Jul; 68(1):75-84. PubMed ID: 22509929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
    Sapir T; Carp H; Shoenfeld Y
    Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a Role of Intravenous Immunoglobulin in Immunologic Recurrent Pregnancy Loss?
    Yang X; Meng T
    J Immunol Res; 2020; 2020():6672865. PubMed ID: 33426092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstetrical outcome of anti-inflammatory and anticoagulation therapy in women with recurrent pregnancy loss or unexplained infertility.
    Han AR; Ahn H; Vu P; Park JC; Gilman-Sachs A; Beaman K; Kwak-Kim J
    Am J Reprod Immunol; 2012 Nov; 68(5):418-27. PubMed ID: 22835220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL).
    Ahmadi M; Abdolmohammadi-Vahid S; Ghaebi M; Aghebati-Maleki L; Afkham A; Danaii S; Abdollahi-Fard S; Heidari L; Jadidi-Niaragh F; Younesi V; Nouri M; Yousefi M
    Biomed Pharmacother; 2017 Aug; 92():1095-1102. PubMed ID: 28622710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin.
    Vaquero E; Lazzarin N; Valensise H; Menghini S; Di Pierro G; Cesa F; Romanini C
    Am J Reprod Immunol; 2001 Mar; 45(3):174-9. PubMed ID: 11270643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss.
    Ahmadi M; Ghaebi M; Abdolmohammadi-Vahid S; Abbaspour-Aghdam S; Hamdi K; Abdollahi-Fard S; Danaii S; Mosapour P; Koushaeian L; Dolati S; Rikhtegar R; Oskouei FD; Aghebati-Maleki L; Nouri M; Yousefi M
    J Cell Physiol; 2019 Jun; 234(6):9428-9437. PubMed ID: 30317625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin G treatment increases live birth rate in women with recurrent miscarriage and modulates regulatory and exhausted regulatory T cells frequency and function.
    Jafarzadeh S; Ahmadi M; Dolati S; Aghebati-Maleki L; Eghbal-Fard S; Kamrani A; Behrad B; Roshangar L; Jadidi-Niaragh F; Yousefi B; Mehdipour M; Farzadi L; Yousefi M
    J Cell Biochem; 2019 Apr; 120(4):5424-5434. PubMed ID: 30326143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion.
    Winger EE; Reed JL
    Am J Reprod Immunol; 2008 Jul; 60(1):8-16. PubMed ID: 18422811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Immunoglobulin Suppresses Abortion Relates to an Increase in the CD44bright NK Subset in Recurrent Pregnancy Loss Model Mice.
    Tanaka J; Kitashoji A; Fukunaga Y; Kashihara J; Nakano A; Kamizono A
    Biol Reprod; 2016 Aug; 95(2):37. PubMed ID: 27335067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion.
    Ramos-Medina R; García-Segovia A; Gil J; Carbone J; Aguarón de la Cruz A; Seyfferth A; Alonso B; Alonso J; León JA; Alecsandru D; Meliá E; Carrillo de Albornoz E; Ordoñez D; Santillán I; Verdú V; Garcia Ruiz de Morales JM; López-Hoyos M; López Larios A; Sampalo A; Caballero P; Ortiz Quintana L; Fernández-Cruz E; Sánchez-Ramón S
    Am J Reprod Immunol; 2014 May; 71(5):458-66. PubMed ID: 24612159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous Immunoglobulin G Improves Pregnancy Outcome in Women with Recurrent Pregnancy Losses with Cellular Immune Abnormalities.
    Lee SK; Kim JY; Han AR; Hur SE; Kim CJ; Kim TH; Cho BR; Han JW; Han SG; Na BJ; Kwak-Kim J
    Am J Reprod Immunol; 2016 Jan; 75(1):59-68. PubMed ID: 26510488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.
    Dendrinos S; Sakkas E; Makrakis E
    Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin G infusion treatment for women with recurrent spontaneous abortions and elevated CD56+ natural killer cells.
    Kwak JY; Kwak FM; Gilman-Sachs A; Beaman KD; Cho DD; Beer AE
    Early Pregnancy (Cherry Hill); 2000 Apr; 4(2):154-64. PubMed ID: 11723544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor inhibitor combined with intravenous immunoglobulin and heparin for treatment of recurrent spontaneous abortion: A two-centre, retrospective, cohort study.
    Jiang Y; Zou Q; Zhang N; Chen J; Chen X; You Q; Wu H
    J Clin Pharm Ther; 2022 Dec; 47(12):2320-2324. PubMed ID: 36511097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion.
    Ruiz JE; Kwak JY; Baum L; Gilman-Sachs A; Beaman KD; Kim YB; Beer AE
    Am J Reprod Immunol; 1996 Apr; 35(4):370-5. PubMed ID: 8739456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.